Citius Oncology, Inc. CTOR Other operating expenses
Other operating expenses at other companies
Other financials
Where this comes from
Reported directly by Citius Oncology, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingExpenses.
The official record: Citius Oncology, Inc.’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →
Ask your AI about Citius Oncology, Inc.'s other operating expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Citius Oncology, Inc.'s other operating expenses?
- Citius Oncology, Inc. (CTOR) reported other operating expenses of $29.95M in Q1 2026.
- How has Citius Oncology, Inc.'s other operating expenses changed year-over-year?
- Citius Oncology, Inc.'s other operating expenses increased by 300.9% year-over-year, from $7.47M to $29.95M.
- What is the long-term trend for Citius Oncology, Inc.'s other operating expenses?
- Over 2 years (2023 to 2025), Citius Oncology, Inc.'s other operating expenses has grown at a 39.3% compound annual growth rate (CAGR), from $12.12M to $23.52M.
- What does other operating expenses mean?
- Residual operating expenses not classified into specific categories, serving as a catch-all for miscellaneous operating costs.